Rule of 30 to asses obstestric haemorrhage
Rule of 30 obstetric haemorrhage assessment clinical
"rule of 30" postpartum hemorrhage
https://pmc.ncbi.nlm.nih.gov/articles/PMC9313855
| Parameter | Change indicating ~30% blood loss |
|---|---|
| Systolic Blood Pressure | Falls by 30 mmHg |
| Heart Rate | Rises by 30 beats per minute |
| Haematocrit | Falls by 30% |
| Haemoglobin | Falls by 30% (approximately 3 g/dL) |
30% blood loss = patient's weight (kg) × 100 × 0.30 mL
| Class | Blood loss | HR | SBP | Signs |
|---|---|---|---|---|
| I | <15% | <100 | Normal | Minimal |
| II | 15-30% | 100-120 | Normal/slightly ↓ | Anxiety, delayed cap refill |
| III | 30-40% | 120-140 | ↓ | Confusion, pallor |
| IV | >40% | >140 | Very ↓ | Lethargy, cold/clammy |
Falls by 30 mmhg means
| Situation | Systolic BP |
|---|---|
| Patient's normal/baseline BP | 120 mmHg |
| After ~30% blood loss | 90 mmHg |
| Difference | 30 mmHg fall |
Ix
| Investigation | What you're looking for |
|---|---|
| Vital signs (HR, BP, RR, SpO₂, temp) | Haemodynamic compromise - apply Rule of 30 and Shock Index |
| Urine output (catheterise) | Target ≥ 30 mL/hour - reflects end-organ perfusion |
| Capillary refill, skin colour/temp | Peripheral shutdown in shock |
| Test | Relevance |
|---|---|
| FBC (Full Blood Count) | Haemoglobin, haematocrit (note: may be normal early - haemodilution takes time), platelet count |
| Blood group & crossmatch | Essential - request 4-6 units packed red cells in major haemorrhage |
| Coagulation screen - PT, APTT, fibrinogen | Detect coagulopathy/DIC which complicates major PPH |
| Fibrinogen level | Low fibrinogen (<2 g/L) predicts severity; <1 g/L = critical, give cryoprecipitate/fibrinogen concentrate |
| D-dimer | Elevated in DIC |
| Thromboelastography (TEG) / ROTEM | Point-of-care viscoelastic test - gives real-time picture of clot formation and lysis; guides blood product therapy |
| Test | Relevance |
|---|---|
| U&E / Renal function | Baseline + monitor for acute kidney injury (AKI) |
| LFTs | Relevant if HELLP syndrome or liver trauma is suspected |
| Serum lactate | Marker of tissue hypoperfusion/anaerobic metabolism - rising lactate = inadequate resuscitation |
| ABG (Arterial Blood Gas) | pH, base deficit, lactate, haemoglobin - rapid bedside assessment of metabolic acidosis and oxygen-carrying capacity |
| Modality | Indication |
|---|---|
| Ultrasound (USS) - bedside | Retained products of conception (RPOC), uterine atony assessment, intra-abdominal free fluid (FAST scan in trauma), placenta accreta complications |
| CT Angiography | Identify source of bleeding for embolisation; used in stable or stabilised patients |
| MRI | Rarely used acutely; useful for placenta accreta spectrum pre-delivery |
Do not delay treatment to wait for results. Resuscitation runs in parallel with investigations. In massive haemorrhage, activate the major haemorrhage protocol and transfuse on clinical grounds if crossmatched blood is not yet available (use O-negative packed red cells).
Why we asses it
A woman can lose 1,000-1,500 mL and still have a normal BP and only mildly raised HR
| Severity | Action |
|---|---|
| Minor loss, no haemodynamic change | Oxytocin, monitor closely |
| Rule of 30 triggered | IV access × 2, fluids, bloods, escalate |
| Class III shock | Blood transfusion, surgical intervention |
| Class IV / DIC | Massive haemorrhage protocol, ICU |
I mean for each investigation I need justification for why we doing this ix
| Investigation | Why we do it |
|---|---|
| Vital signs (HR, BP, RR, SpO₂) | HR rises before BP falls - earliest sign of haemodynamic compromise. Allows application of Rule of 30 and Shock Index to quantify severity in real time |
| Urine output (catheterise) | Kidneys are the first organ to show hypoperfusion. Output <30 mL/hr = inadequate end-organ perfusion = still in shock despite normal-looking BP |
| Capillary refill / skin | Peripheral vasoconstriction is an early compensatory response - cold, pale, clammy peripheries indicate the body is shunting blood to vital organs |
| Investigation | Why we do it |
|---|---|
| FBC | Haemoglobin and haematocrit confirm the degree of blood loss (Rule of 30: Hb falls ~3 g/dL, haematocrit falls 30%). Platelet count detects thrombocytopaenia which worsens bleeding. Caveat: in acute haemorrhage, Hb may be normal initially because haemodilution has not yet occurred - do not be falsely reassured |
| Blood group & crossmatch | You need compatible blood ready before the patient deteriorates further. In massive haemorrhage every minute counts - this must be sent immediately, not when the patient is already in crisis |
| Coagulation screen (PT, APTT) | Major haemorrhage consumes clotting factors. Prolonged PT/APTT signals coagulopathy or early DIC - you cannot control bleeding without functioning clotting |
| Fibrinogen | The single most important coagulation test in PPH. Fibrinogen is consumed rapidly in PPH. Level <2 g/L predicts progression to severe PPH. Level <1 g/L = critical - replace immediately with cryoprecipitate or fibrinogen concentrate. Normal pregnancy fibrinogen is 4-6 g/L so "normal" non-pregnant ranges are misleading |
| D-dimer | Elevated in DIC due to fibrin degradation. Confirms consumptive coagulopathy when combined with low fibrinogen and prolonged clotting times |
| TEG / ROTEM | Standard coagulation tests take 45-60 minutes. TEG/ROTEM gives a real-time, whole-blood picture of clot formation, strength, and lysis within minutes. Tells you exactly which component is failing - red cells, platelets, fibrinogen, or fibrinolysis - so you give the right blood product rather than guessing |
| Investigation | Why we do it |
|---|---|
| U&E / Renal function | Establishes baseline kidney function. Prolonged hypoperfusion causes acute tubular necrosis (ATN) and AKI - serial measurements track whether kidneys are recovering or failing |
| LFTs | If HELLP syndrome, liver capsule haematoma, or hepatic trauma is a possible cause of haemorrhage, LFTs identify liver involvement. Also important before giving drugs metabolised hepatically |
| Serum lactate | Lactate rises when tissues switch to anaerobic metabolism due to inadequate oxygen delivery. A rising lactate despite fluid resuscitation means the patient is not adequately perfused - your treatment is not working. Target lactate <2 mmol/L |
| ABG (Arterial Blood Gas) | Gives you five critical pieces of information simultaneously and immediately: pH (acidosis = severity of shock), base deficit (quantifies metabolic derangement), lactate (perfusion), HCO₃ (compensation), and haemoglobin (oxygen-carrying capacity). Faster and more comprehensive than waiting for lab results |
| Investigation | Why we do it |
|---|---|
| Bedside USS | Identifies retained products of conception (a cause of ongoing bleeding), assesses uterine tone, detects intra-abdominal free fluid (haemoperitoneum after uterine rupture or trauma), and evaluates for placenta accreta complications. Done at the bedside without moving an unstable patient |
| CT Angiography | Identifies the precise arterial source of bleeding so interventional radiology can perform uterine artery embolisation (UAE) - a uterus-sparing alternative to surgery. Only used in haemodynamically stable or stabilised patients |
| MRI | Not used acutely. Used antenatally to characterise placenta accreta spectrum (depth of invasion) to plan delivery. Occasionally post-operatively to assess complications |
Prophylactic oxytocis means
| Component | Purpose |
|---|---|
| Oxytocin 10 IU IM (or IV infusion) given at/after birth | Prevent atony - this is the prophylactic part |
| Controlled cord traction | Deliver placenta quickly and cleanly |
| Uterine massage (in some guidelines) | Sustain contraction |
| Prophylactic | Therapeutic | |
|---|---|---|
| When given | Before bleeding, routinely at delivery | After PPH has already occurred |
| Purpose | Prevent atony | Treat atony that has happened |
| Dose | 10 IU IM single dose | Higher doses, IV infusion |
| Goal | Primary prevention | Stop active haemorrhage |
Prophylactic oxytocin is the single most effective intervention for preventing PPH and is recommended for all women at every delivery by WHO, FIGO, and RCOG - regardless of risk level.
Uterotonic agent
| Feature | Detail |
|---|---|
| Class | Synthetic posterior pituitary hormone |
| Mechanism | Binds oxytocin receptors on myometrium → increases intracellular Ca²⁺ → uterine contraction |
| Dose (prophylactic) | 10 IU IM at delivery of anterior shoulder |
| Dose (therapeutic) | 20-40 IU in 500 mL Normal Saline IV infusion |
| Onset | IM: 3-5 min / IV: immediate |
| Side effects | Hypotension (especially IV bolus), tachycardia, nausea, water retention (antidiuretic effect) |
| Contraindications | Avoid large IV bolus in cardiac disease |
| First line | YES - first line for both prevention and treatment of PPH |
| Feature | Detail |
|---|---|
| Class | Ergot alkaloid |
| Mechanism | Acts on α-adrenergic and serotonin receptors → sustained tonic uterine contraction |
| Dose | 0.2-0.5 mg IM or slow IV |
| Onset | IM: 2-5 min / IV: immediate |
| Side effects | Hypertension, nausea, vomiting, coronary vasospasm |
| Contraindications | Hypertension, pre-eclampsia, cardiac disease - causes vasoconstriction systemically |
| Note | Often combined with oxytocin as Syntometrine (oxytocin 5 IU + ergometrine 0.5 mg IM) |
| Feature | Detail |
|---|---|
| Class | Prostaglandin F₂α analogue |
| Mechanism | Binds prostaglandin receptors on myometrium → strong sustained contraction |
| Dose | 250 mcg IM, can repeat every 15-90 min, max 8 doses (2 mg total) |
| Side effects | Bronchospasm, diarrhoea, vomiting, flushing, hypertension |
| Contraindications | Asthma - causes bronchospasm |
| Use | Second line when oxytocin fails |
| Feature | Detail |
|---|---|
| Class | Prostaglandin E₁ analogue |
| Mechanism | Binds PGE receptors → uterine contraction |
| Dose | 600-1000 mcg - sublingual, oral, or rectal |
| Side effects | Shivering, pyrexia, diarrhoea |
| Contraindications | Few - no significant cardiovascular effects |
| Advantage | Stable at room temperature, cheap, no injection needed - ideal for low-resource settings and home deliveries |
| Use | Alternative first line where oxytocin unavailable; also used rectally in unconscious patients |
| Feature | Detail |
|---|---|
| Class | Long-acting oxytocin analogue |
| Mechanism | Same as oxytocin but longer duration of action |
| Dose | 100 mcg IV or IM single dose |
| Duration | Single dose lasts ~1 hour (vs oxytocin needing infusion) |
| Advantage | Heat-stable formulation now available (WHO recommended) - useful in resource-limited settings |
| Use | Prophylaxis at caesarean section particularly |
| Drug | Route | Contraindication | Key Advantage |
|---|---|---|---|
| Oxytocin | IV/IM | Avoid IV bolus in cardiac disease | First line, safest |
| Ergometrine | IM/IV | Hypertension, pre-eclampsia | Sustained tonic contraction |
| Syntometrine | IM | Hypertension | Combined effect |
| Carboprost | IM | Asthma | Powerful, second line |
| Misoprostol | SL/oral/rectal | Few | No injection, heat stable |
| Carbetocin | IV/IM | - | Long acting, single dose |
Oxytocin (first line)
↓ fails
Ergometrine or Syntometrine
↓ fails
Carboprost (if no asthma)
↓ fails
Misoprostol (if not already given)
↓ fails
Surgical / interventional options
Oxytocin - Ergometrine - Carboprost - Misoprostol "Only Ever Consider More" when the previous one fails
Management
| T | Cause | Frequency |
|---|---|---|
| Tone | Uterine atony | 70-80% |
| Tissue | Retained placenta/clots | ~10% |
| Trauma | Lacerations, uterine rupture | ~10% |
| Thrombin | Coagulopathy/DIC | ~1% |
CONSERVATIVE (bedside)
H → A → E → M → O
↓
SURGICAL (theatre)
S (shift) → T → A → S (devascularisation)
↓
RADIOLOGICAL
I (UAE)
↓
DEFINITIVE SURGERY
S (Hysterectomy)
The principle is escalate stepwise but do not delay the next step if a measure is clearly failing. In a rapidly deteriorating patient, move faster through the algorithm.